LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹151 Cr | ₹164 Cr | ₹209 Cr | ₹208 Cr | ₹229 Cr |
What is the latest Total Liabilities ratio of LASA SUPERGENERICS ?
| Year | Total Liabilities |
|---|---|
| Mar2024 | ₹151 Cr |
| Mar2023 | ₹164 Cr |
| Mar2022 | ₹209 Cr |
| Mar2021 | ₹208 Cr |
| Mar2020 | ₹229 Cr |
How is Total Liabilities of LASA SUPERGENERICS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹151 Cr | -7.93 | |
| Mar2023 | ₹164 Cr | -21.66 | |
| Mar2022 | ₹209 Cr | 0.63 | |
| Mar2021 | ₹208 Cr | -9.16 | |
| Mar2020 | ₹229 Cr | - | |
Compare Total Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹45.7 Cr | -0.4% | -5% | -67.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -0.4% |
-5% |
-67.2% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses